CRE8 in All Comers Patients

NCT01687075 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

215

Enrollment

OTHER_GOV

Sponsor class

Conditions

Consecutive Subjects Who Are Suitable for a Coronary
Angioplasty of de Novo Lesion(s) in Native Coronary
Arteries Should be Screened for Eligibility.
A Total Number of 200 Patients Fulfilling the Selection
Criteria and Willing to Sign the Informed Consent Should
be Enrolled in the Trial.

Interventions

DEVICE: CR8 a drug eluting coronary stent

Sponsor

Tel-Aviv Sourasky Medical Center